e-learning resources

ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Current challenges in COPD evaluation

Poster Discussion
Chairs: C. Suppli Ulrik (Virum, Denmark), E. Márquez Martín (Sevilla, Spain)

Download all media

Download all media

The effect of changing GOLD severity stage on long-term mortality in COPD J. Chalmers (Dundee, United Kingdom)
The value of FENO50 measurement in COPD – results from the TIE-study A. Thornadtsson (Gävle, Sweden)
Feasibility and clinical impact of deploying a digital health intervention in a Medicare population with COPD J. Chen
Assessment of cytokine mRNA expression in patients with COPD exacerbations C. Páska (Budapest, Hungary)
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort F. Seiler (Saarbrücken, Germany)
Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study M. Nishimura (Sapporo, Japan)
Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis M. Bafadhel (Oxford, United Kingdom)
Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk F. Rassouli (St. Gallen, Switzerland)
Distal airspace radius estimated by nanoparticle deposition reflects lung density L. Aaltonen (Malmo, Sweden)
A systematic review of the accuracy of microspirometry for screening of adults for COPD L. Pinto (Montréal, QC, Canada)
Predicting future development of COPD (MARKO study) M. Labor (Zagreb, Croatia)
Longitudinal measurement of airway inflammation relates to a higher risk of exacerbation in COPD. B. Alcazar Navarrete (Cájar, Spain)
Malnutrition and sarcopenia in chronic obstructive pulmonary disease according to the new ESPEN definition and EWGSOP criteria F. de Blasio (Pozzuoli, NA, Italy)
Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity G. Ali Abo E-Magd (Tanta, Egypt)
Decline in health status in alpha1 antitrypsin deficiency R. Stockley (Birmingham, United Kingdom)
Exacerbations and duration of smoking abstinence are associated with the annual decline in lung function in individuals with PiZZ alpha-1-antitrypsin deficiency S. Fähndrich (Homburg/Saar, Germany)
Exhaled breath temperature in patients with severe asthma starting treatment with omalizumab T. Kralimarkova (Sofia, Bulgaria)
Soluble urokinase-type plasminogen activator receptor in monitoring of treatment response in acute exacerbation of chronic obstructive pulmonary disease G. Ali Abo E-Magd (Tanta, Egypt)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.